|
|
|
Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. You name it, the pharmaceutical industry is working on a vaccine to prevent it. Many could be on the market in five years or less.
Many more could be on the market in five years or less. MARIETTA, Pa. -- Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name...
Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.
Alzheimer’s disease. Contrast that with five years ago, when so many companies had abandoned the vaccine business that half the U.S. supply of flu shots was lost because of contamination at one of the two manufacturers left....
By Kate Kelland LONDON, Nov 18 (Reuters) - Data from the United Nations children's fund (UNICEF) and Global Alliance for Vaccines and Immunisation (GAVI) showed average prices for the shots, which protect against five infant...
NEW YORK , Nov. 16 /PRNewswire/ — MZ Consult NY ( www.mz-ir.com ), a leading global investor relations and financial communications firm, invites all market participants to vote on the Investors' Choice award (POP+) through...
LEIDEN, NETHERLANDS--(Marketwire - November 16, 2009) - Global biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL) ( SWISS : CRX ) today announced the launch of the global Crucell brand, a consistent identity for...
Ransdell Pierson, On 19:34 GMT, Tuesday 3 November 2009 NEW YORK (Reuters) - Johnson & Johnson plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research...
UTRECHT, Netherlands & CAMBRIDGE, England----PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor , today announced it has entered into an agreement with Abbott...
It’s a small shot in the arm, but it could mean big money for pharmaceutical companies around the world. With flu season upon us and swine flu threatening to reach pandemic proportions, Big Pharma is scrambling to join the...
